Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Kenan Turnacioglu
AddedMar 31, 2024
UpdatedJul 16, 2026
Kenan Turnacioglu

Kenan Turnacioglu

Founder, PointState Capital

CrunchbaseLinkedIn

Kenan Turnacioglu's Career

PointState Capital
PointState Capital

Durham, NC, US

Founder
Massive Bio
Massive Bio

New York City, NY, US

Board Member· Board
Immunai
Immunai

New York City, NY, US

Board Member· Board
Paige
Paige

New York City, NY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Kenan Turnacioglu's Career

PointState Capital
PointState Capital
Investment FirmInvestment Firm$71.2M19.1k1838Durham, NC, US
Founder

Leadership at PointState Capital

Lisa BordersLisa BordersBoard Member
Joshua KopenJoshua KopenBoard Member
Rick WagonerRick WagonerBoard Member
Stuart PimmStuart PimmBoard Member
Pamela HawleyPamela HawleyBoard Member
Maggie EppsMaggie EppsBoard Member

Similar to PointState Capital

DumacDumacDurham, NC, USest. 2011DumacDurham, NC, US · est. 2011

Dumac Inc: A Duke University-controlled investment firm providing expert advice since 2017.

Investment Firm7.5k
Duke Impact Investing GroupDuke Impact Investing GroupDurham, NC, USDuke Impact Investing GroupDurham, NC, US

Duke Impact Group: Enhancing access to impactful student-led investment opportunities.

Investment Firm115
Towerview VenturesTowerview VenturesDurham, NC, USest. 2017Towerview VenturesDurham, NC, US · est. 2017

Towerview Ventures: A private venture capital fund for Duke alumni, investing in Duke-connected companies.

Investment Firm12
Purdue Foundry Investment FundPurdue Foundry Investment FundWest Lafayette, IN, USest. 2014Purdue Foundry Investment FundWest Lafayette, IN, US · est. 2014

Leading public research university in West Lafayette, Indiana, USA. Founded in 1869, Purdue is renowned for science and technology.

Investment Firm · $12.7M11.4k
Massive Bio
Massive Bio
Series B$23.8M852015New York City, NY, US
Board Member· Board

Leadership at Massive Bio

Arturo Loaiza-BonillaArturo Loaiza-BonillaCo-Founder
Cagatay M CulcuogluCagatay M CulcuogluCo-Founder
Selin KurnazSelin KurnazCo-Founder
Immunai
Immunai
Series B$295M1672018New York City, NY, US
Board Member· Board

Leadership at Immunai

Stanley FrankelStanley FrankelBoard Member
Dan LittmanDan LittmanCo-Founder
Ansuman SatpathyAnsuman SatpathyCo-Founder
Danny WellsDanny WellsCo-Founder
Noam SolomonNoam SolomonCo-Founder
Zvika OrronZvika OrronBoard Member
Paige
Paige
Series C$220M1452018New York City, NY, US
Board Member· Board

Leadership at Paige

Joseph A. BoystakJoseph A. BoystakBoard Member
Thomas Fuchs, Dr.Sc.Thomas Fuchs, Dr.Sc.Co-Founder & CSO
Asish K. XavierAsish K. XavierBoard Member
David KlimstraDavid KlimstraCo-Founder
David S. Klimstra, MDDavid S. Klimstra, MDCo-Founder & CMO
Peter SchüfflerPeter SchüfflerCo-Founder

Similar to Paige

Glass HealthGlass HealthSan Francisco, CA, USClinical Supportest. 2021Glass HealthSan Francisco, CA, US · est. 2021

Glass Health: AI-assisted clinical support for clinicians, based in San Francisco.

Seed · $7M2
PathAIPathAIBoston, MA, USest. 2016PathAIBoston, MA, US · est. 2016

An AI-powered pathology platform that increases the accuracy of diagnosis and efficacy of treatment.

Late Stage Private · $355.2M360
4D Path4D PathNewton, MA, USCancer Diagnosticsest. 20164D PathNewton, MA, US · est. 2016

A statistical physics and tumor biology platform that unveils hidden data for cancer diagnostics.

Series B · $24.3M12
EnliticEnliticSan Francisco, CA, USDiagnostics, Healthcareest. 2014EnliticSan Francisco, CA, US · est. 2014

A pioneer in medical deep learning that leverages algorithms to improve healthcare diagnosis.

Series B · $65M64

Kenan Turnacioglu's Co-Investors

Arthur PattersonArthur PattersonCo-invested · Sirona Medical Series AJonathan BushJonathan BushCo-invested · Sirona Medical Series AGyan KapurGyan KapurCo-invested · Massive Bio Seed

Kenan Turnacioglu's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Kenan Turnacioglu

Thomas FuchsThomas FuchsCo-Founder · PaigeAedhmar HynesAedhmar HynesBoard Member · Top Technology VenturesWalter JinWalter JinFounder · Three Fields CapitalByron AlsbergByron AlsbergCo-Founder · Prefix CapitalCharles BooradyCharles BooradyFounder · Health Catalyst Capital